Recently, Dixit Deobrat et al. [27] reported that IGF2BP3 played key roles in glioblastoma maintenance and promoting tumour heterogeneity, highlighting its role in the malignant progression of glioma. This evidence concerns the gene IGF2BP3 and central nervous system cancer.